The New Yorker writes about Merck and Vioxx
“While that kind of weighing of risk and benefit may be medically rational, in the legal arena itÂ’s poison.” (via PointofLaw.com)
More in Uncategorized
Past Week
-
Elite access vs. public scrutiny: Medication disparities exposed
-
Talk to your patients about money
-
Too many older adults are taking risky sedative medications
-
The Supreme Court must consider science, not pseudo-science, in public health rulings
-
Navigating organizational dysfunction: lessons from Boeing
-
The Change Healthcare hack: a wake-up call for the health care industry
-
Past 6 Months
-
Medicine is not apolitical: Your vote dictates your ability to practice medicine
-
Elite access vs. public scrutiny: Medication disparities exposed
-
The abuser’s playbook: the weaponization of mental health
-
Real pain deserves real treatment
-
Physician burnout: a surgeon’s story of exhaustion, recovery, and systemic change
-
From fear of loneliness to embracing solitude
-
Recent Posts
-
The Change Healthcare hack: a wake-up call for the health care industry
-
Venture-backed telemental health care companies are creating a new opioid epidemic
-
Working patients and health care [PODCAST]
-
Preventing amputations and saving lives starts with bringing PAD into the 21st century
-
Optimizing IUD placement: prescribed medications and timing tips
-
AI’s role in simplifying communication [PODCAST]
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
